• 1
    de Bueger M, Bakker A, van Rood JJ, van der Woude F, Goulmy E: Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 1992; 149:17881794.
  • 2
    Hambach L, Spierings E, Goulmy E: Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens. Best Pract Res Clin Haematol 2007; 20:171187.
  • 3
    Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, Hegland J, Kamani N, Keman NA, King R, Ratanatharathorn V, Weisdorf D, Confer DL: Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001; 98:20432051.
  • 4
    Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM, Loberiza FR, Porter DL: Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12:758769.
  • 5
    Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ, Hochberg EP, Wu CJ, Alyea EP, Cutter S, Ho V, Soiffer RJ, Antin JH, Ritz J: Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005; 105:29732978.
  • 6
    James E, Chai JG, Dewchand H, Macchiarulo E, Dazzi F, Simpson E: Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood 2003; 102:388393.
  • 7
    Verdijk RM, Kloosterman A, Pool J, van de Keur M, Naipal AM, van Halteren AG, Brand A, Mutis T, Goulmy E: Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 2004; 103:19611964.
  • 8
    Miklos DB, Kim HT, Zorn E, Hochberg EP, Guo L, Mattes-Ritz A, Viatte S, Soiffer RJ, Antin JH, Ritz J: Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 2004; 103:353359.
  • 9
    Nielsen HS, Andersen AM, Kolte AM, Christiansen OB: A firstborn boy is suggestive of a strong prognostic factor in secondary recurrent miscarriage: a confirmatory study. Fertil Steril 2008; 89:907911.
  • 10
    Ooi PV, Russell N, O′Donoghue K: Secondary recurrent miscarriage is associated with previous male birth. J Reprod Immunol 2011; 88:3841.
  • 11
    Nielsen HS, Steffensen R, Lund M, Egestad L, Mortensen LH, Andersen AM, Lidegaard O, Christiansen OB: Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage. Hum Reprod 2010; 25:15431552.
  • 12
    Byrne J, Warburton D: Male excess among anatomically normal fetuses in spontaneous abortions. Am J Med Genet 1987; 26:605611.
  • 13
    Nielsen HS, Mortensen L, Nygaard U, Schnor O, Christiansen OB, Andersen AM: Brothers and reduction of the birth weight of later-born siblings. Am J Epidemiol 2008; 167:480484.
  • 14
    Magnus P, Berg K, Bjerkedal T: The association of parity and birth weight: testing the sensitization hypothesis. Early Hum Dev 1985; 12:4954.
  • 15
    Blanchard R, Ellis L: Birth weight, sexual orientation and the sex of preceding siblings. J Biosoc Sci 2001; 33:451467.
  • 16
    Cote K, Blanchard R, Lalumiere ML: The influence of birth order on birth weight: does the sex of preceding siblings matter? J Biosoc Sci 2003; 35:455462.
  • 17
    Nielsen HS, Mortensen L, Nygaard U, Schnor O, Christiansen OB, Andersen AMN: Sex of prior children and risk of stillbirth in subsequent pregnancies. Epidemiology 2010; 21:114117.
  • 18
    Nielsen HS, Steffensen R, Varming K, van Halteren AG, Spierings E, Ryder LP, Goulmy E, Christiansen OB: Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy. Hum Mol Genet 2009; 18:16841691.
  • 19
    Nielsen HS, Mogensen M, Steffensen R, Kruse C, Christiansen OB: Indications of anti-HY immunity in recurrent placental abruption. J Reprod Immunol 2007; 75:6369.
  • 20
    Ahrons S: HL-A antibodies: influence on the human fetus. Tissue Antigens 1971; 1:129136.
  • 21
    Balasch J, Ercilla G, Vanrell JA, Vives J, Gonzalez-Merlo J: Effects of HLA antibodies on pregnancy. Obstet Gynecol 1981; 57:444446.
  • 22
    Regan L, Braude PR, Hill DP: A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991; 6:294298.
  • 23
    Beard RW, Braude P, Mowbray JF, Underwood JL: Protective antibodies and spontaneous abortion. Lancet 1983; 2:1090.
  • 24
    Johnson PM, Barnes RM, Hart CA, Francis WJ: Determinants of immunological responsiveness in recurrent spontaneous abortion. Transplantation 1984; 38:280284.
  • 25
    Power DA, Catto GR, Mason RJ, MacLeod AM, Stewart GM, Stewart KN, Shewan WG: The fetus as an allograft: evidence for protective antibodies to HLA-linked paternal antigens. Lancet 1983; 2:701704.
  • 26
    McIntyre JA, McConnachie PR, Taylor CG, Faulk WP: Clinical, immunological and genetic definitions of primary and secondary recurrent spontaneous abortions. Fertil Steril 1984; 42:849855.
  • 27
    Steinborn A, Seidl C, Sayehli C, Sohn C, Seifried E, Kaufmann M, Schmitt E: Anti-fetal immune response mechanisms may be involved in the pathogenesis of placental abruption. Clin Immunol 2004; 110:4554.
  • 28
    Nielsen HS, Witvliet MD, Steffensen R, Haasnoot GW, Goulmy E, Christiansen OB, Claas F: The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of live birth. J Reprod Immunol 2010; 87:6773.
  • 29
    Nielsen HS, Wu F, Aghai Z, Steffensen R, van Halteren AG, Spierings E, Christiansen OB, Miklos D, Goulmy E: HY antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male:female ratio in subsequent live births. Hum Reprod 2010; 25:27452752.
  • 30
    van Els CA, Zantvoort E, Jacobs N, Bakker A, van Rood JJ, Goulmy E: Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules. Bone Marrow Transplant 1990; 5:365372.
  • 31
    Zelenika D, Adams E, Mellor A, Simpson E, Chandler P, Stockinger B, Waldman H, Cobbold SP: Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J Immunol 1998; 161:18681874.
  • 32
    Spierings E, Vermeulen CJ, Vogt MH, Doerner LE, Falkenburg JH, Mutis T, Goulmy E: Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y- mismatched transplantation. Lancet 2003; 362:610615.
  • 33
    Ramalho MF, Garcia JM, Esper CR, Vantini R, Alves BC, Meida Junior IL, Hossepian de Lima VF, Moreira-Filho CA: Sexing of murine and bovine embryos by developmental arrest induced by high-titer H-Y antisera. Theriogenology 2004; 62:15691576.
  • 34
    Utsumi K, Hayashi M, Takakura R, Utaka K, Iritani A: Embryo sex selection by a rat male-specific antibody and the cytogenetic and developmental confirmation in cattle embryos. Mol Reprod Dev 1993; 34:2532.
  • 35
    Sargent IL, Wilkins T, Redman CW: Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet 1988; 2:10991104.
  • 36
    Coulam CB: Immunological tests in the evaluation of reproductive disorders: a critical review. Am J Obstet Gynecol 1992; 167:18441851.
  • 37
    Atkinson K, Farrell C, Chapman G, Downs K, Penny R, Biggs J: Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol 1986; 63:231239.
  • 38
    Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E, Good RA, Hoffmann RG, Kay HE, Kersey JH: Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67:397406.
  • 39
    Carlens S, Ringden O, Remberger M, Lonnqvist B, Hagglund H, Klaesson S, Mattson J, Svahn BM, Winiarski J, Ljungman P, Aschan J: Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 1998; 22:755761.
  • 40
    Gratwohl A, Hermans J, Niederwieser D, van Biezen A, van Houwelingen HC, Apperley J: Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J 2001; 2:363370.
  • 41
    Huppertz B, Kadyrov M, Kingdom JC: Apoptosis and its role in the trophoblast. Am J Obstet Gynecol 2006; 195:2939.
  • 42
    Adams KM, Yan Z, Stevens AM, Nelson JL: The changing maternal ‘self’ hypothesis: a mechanism for maternal tolerance of the fetus. Placenta 2007; 28:378382.
  • 43
    Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21:685711.
  • 44
    Gerber S, Vardhana S, Meagher-Villemure K, Vial Y, Hohlfeld P, Witkin SS: Association between fetal interleukin-1 receptor antagonist gene polymorphism and unexplained fetal death. Am J Obstet Gynecol 2005; 193:14721477.
  • 45
    Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE: Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 2006; 203:21652175.
  • 46
    Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW: Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178:59495956.
  • 47
    Arruvito L, Sanz M, Banham AH, Fainboim L: Expansion of CD4+CD25+ and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007; 178:25722578.